Araiza-Olivera, D, Feng Y, Semenova G, Prudnikova TY, Rhodes J, Chernoff J. Suppression of RAC1-driven malignant melanoma by group A PAK inhibitors. 2018 Oncogene 37:944-952. PMCID: PMC5814328
Chow HY, Dong B, Valencia CA, Zeng CT, Koch JN, Prudnikova TY, Chernoff J. Group I Paks are essential for epithelial-mesenchymal transition in an Apc-driven model of colorectal cancer. 2018 Nature Communications 9:3473. PMCID: PMC6110733
Francescone, R., Vendramini-Costa, D.B., Franco-Barraza, J., Wagner, J., Muir, A., Lau, A.N., Gabitova, L., Pazina, T., Gupta, S., Luong, T., Shah, N., Rollins, D., Malik, R., Thapa, R., Restifo, D., Zhou, Y., Cai, K.Q., Hensley, H.H., Tan, Y., Kruger, W.D., Devarajan, K., Balachandran, S., Klein-Szanto, A.J., El-Deiry, W.S., Vander Heiden, M.G., Peri, S., Campbell, K.S., Astsaturov, I., and Cukierman, E. Netrin G1/NGL-1 axis promotes pancreatic tumorigenesis through cancer associated fibroblast driven nutritional support and immunosuppression. 2020. Cancer Discov. 11:446-479, PMCID: PMC7858242.
Gabitova-Cornell, L., Surumbayeva, A., Peri, S., Franco-Barraza, J., Restifo, D., Weitz, N., Ogier,. C, Goldman, A.R., Hartman, T.R., Francescone, R., Tan, Y., Nicolas, E., Shah, N., Handorf, E.A., Cai, K.Q., O'Reilly, A.M., Sloma, I., Chiaverelli, R., Moffitt, R.A., Khazak, V., Fang, C.Y., Golemis, E.A., Cukierman, E., Astsaturov, I. Cholesterol pathway inhibition induces TGF-β signaling to promote basal differentiation in pancreatic cancer. 2020 Cancer Cell 38:567-583, PMCID: PMC7572882.
Nacson J, Krais JJ, Bernhardy AJ, Clausen E, Feng W, Wang Y, Nicolas E, Cai KQ, Tricarico R, Hua X, DiMarcantonio D, Martinez E, Zong D, Handorf EA, Bellacosa A, Testa JR, Nussenzweig A, Gupta GP, Sykes SM, Johnson N. BRCA1 Mutation-Specific Responses to 53BP1 Loss-Induced Homologous Recombination and PARP Inhibitor Resistance. 2018 Cell Rep. 25:3513-3527. PMCID: PMC6219632
Nacson J., Di Marcantonio, D., Wang., Y., Bernhardy, A.J., Clausen, E., Hua, X., Cai, K.Q., Martinez, E., Feng, W., Callén, E., Wu, W., Gupta, G.P., Testa, J.R., Nussenzweig, A., Sykes, S.M., Johnson, N. BRCA1 mutational complementation induces synthetic viability. 2020 Mol. Cell 78:951-959. PMCID: PMC7418109.
Nogusa, S., Thapa, R.J., Dillon, C.P., Liedmann, S., Oguin, T.H., 3rd, Ingram, J.P., Rodriguez, D.A., Kosoff, R., Sharma, S., Sturm, O., Verbist, K., Gough, P.J., Bertin, J., Hartmann, B.M., Sealfon, S.C., Kaiser, W.J., Mocarski, E.S., Lopez, C.B., Thomas, P.G., Oberst, A., Green, D.R., Balachandran, S. RIPK3 activates parallel pathways of NLKL-driven necroptosis and FADD-mediated apoptosis to protect against influenza A virus. 2016 Cell Host Microbe 20:13-24, 2016. PMCID: PMC5026823.
Pazina, T., James, A.M., Colby, K.B., Yang, Y., Gale, A., Jhatakia, A., Kearney, A., Bezman, N.A., Graziano, R.F., Robbins, M.D., Cohen, A.D., Campbell, K.S. Enhanced SLAMF7 homotypic interactions by elotuzumab improves NK cell killing of multiple myeloma. 2019 Cancer Immunol. Res. 7:1633-1646. PMCID: PMC6774869
Zhang, T., Yin, C., Boyd, D.F., Quarato, G., Ingram, J.P., Shubina, M., Ragan, K.B., Ishizuka, T., Chase Crawford, J., Tummers, B., Rodriguez, D.A., Xue, J., Peri, S., Kaise, W.J., López, C.B., Xu, Y., Upton, J.W., Thomas, P.G., Green, D.R., Balachandran, S. Influenza Virus Z-RNAs Induce ZBP1-Mediated Necroptosis. 2020 Cell 180:1115-1129. PMCID: PMC7153753.
Zhao, Z., Fowle, H., Valentine, H., Liu, Z., Tan, Y., Pei, J., Badal, S., Testa, J.R., Graña, X. Immortalization of human primary prostate epithelial cells via CRISPR inactivation of the CDKN2A locus and expression of telomerase. Prostate Cancer Prostatic Dis. 2021, 24: 233–243. PMCID: PMC7917161.